查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529804

稀有细胞隔离市场规模、份额、趋势分析报告：按产品类型、细胞类型、技术、地区和细分市场预测，2024-2030 年

Rare Cell Isolation Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instrument), By Cell Type (Circulating Tumor Cells, Stem Cells), By Technology, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

稀有细胞分离市场的成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球稀有细胞分离市场规模将达34.6亿美元，2024年至2030年复合年增长率为9.71%。

这是由持续的技术进步、慢性病盛行率的增加、对个人化医疗的需求不断增长以及癌症研究的进步所推动的。此外，稀有干细胞的分离对于再生医学和干细胞治疗至关重要，从而推动了预测期内的需求。

COVID-19 大流行加速了诊断和治疗研究的进展，对市场产生了积极影响。了解病毒和开发有效治疗方法的迫切需求促使人们对尖端细胞分离技术进行投资，以促进稀有免疫细胞和循环病毒颗粒的快速分离和分析。因此，不断增长的需求将推动整个生物技术产业的创新和合作，从而增强单细胞分析、液态切片、个人化医疗的能力，并且在预测期内对稀有细胞分离的需求不断增加。

慢性疾病，特别是癌症的盛行率不断增加，显着增加了对稀有细胞分离技术的需求。分离这些细胞可以进行早期诊断、监测治疗效果并为个别患者开发标靶治疗。透过捕捉和治疗这些稀有细胞，研究人员和临床医生可以识别特定的基因突变，识别肿瘤行为，制定个人化的治疗计划，并最终改善患者的治疗结果，有望改善肿瘤学领域并推动肿瘤学领域的发展。因此，对用于预测行为的稀有细胞的需求不断增长预计将推动预测期内的市场成长。

然而，微射流和流式细胞技术等先进的稀有细胞分离技术通常需要大量投资。昂贵的设备、试剂和维护成本让许多研究机构和临床实验室望而却步，限制了市场的扩张。此外，分离稀有细胞的过程在技术上很复杂，需要专门的知识和训练。这种复杂性预计将成为采用的障碍并进一步阻碍市场成长。

稀有细胞隔离市场报告亮点

  • 试剂和套件领域预计将在2023年占据市场主导地位，并在2024年至2030年以最快的复合年增长率成长。与复杂且昂贵的细胞分离设备相比，试剂和套件的成本效益在其广泛使用中发挥重要作用。
  • 2023年，干细胞细分市场占比最大，为39.46%。製药和生物技术产业严重依赖分离的干细胞来筛检新药、研究细胞反应并评估潜在治疗方法的安全性。研究和工业领域的广泛应用巩固了该领域的主导地位。
  • 2023 年，基于微流体的技术领域占据市场主导地位。微流体技术的不断创新和进步有助于其在市场上的主导地位。研究人员和公司正在开发新的微流体设备和技术，以提供改进的性能、易用性以及与其他分析工具的整合。这些进步正在推动基于微流体的细胞分离的广泛使用和扩大应用。
  • 由于癌症发病率上升、久坐的生活方式以及慢性病盛行率上升，北美将在 2023 年占据市场主导地位。同时，亚太地区预计在预测期内将以最高的复合年增长率成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章稀有细胞分离市场的变数、趋势和范围

  • 市场体系展望
  • 市场动态
  • 稀有细胞分离市场分析工具

第 4 章 稀有细胞分离市场：依产品估算与趋势分析

  • 细分仪表板
  • 全球稀有细胞分离市场：产品波动分析
  • 全球稀有细胞分离市场：规模和趋势分析（按产品），2018-2030
  • 试剂和套件
  • 装置

第五章稀有细胞分离市场：依细胞类型估算与趋势分析

  • 细分仪表板
  • 全球稀有细胞分离市场：依细胞类型进行差异分析
  • 全球稀有细胞分离市场：规模和趋势分析（按细胞类型），2018-2030
  • 循环性肿瘤细胞
  • 干细胞
  • 胎儿细胞
  • 稀有免疫细胞
  • 循环内皮细胞
  • 其他稀有细胞类型

第六章稀有细胞分离市场：技术估算与趋势分析

  • 细分仪表板
  • 全球稀有细胞分离市场：技术变迁分析
  • 全球稀有细胞分离市场：规模与趋势分析（按技术），2018-2030
  • 微流体技术
  • 萤光活化细胞分选
  • 磁珠分离

第七章稀有细胞分离市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 2018-2030年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018年至2030年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Miltenyi Biotec
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • QIAGEN NV
    • Bio-techne
    • STEMCELL Technologies
    • CELLENION
    • RareCyte
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
Product Code: GVR-4-68040-359-9

Rare Cell Isolation Market Growth & Trends:

The global rare cell isolation market size is anticipated to reach USD 3.46 billion by 2030, registering a CAGR of 9.71% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is attributed to the continuous technological advancements, increasing prevalence of chronic diseases, growing demand for personalized medicine, and advancements in cancer research. Furthermore, the isolation of rare stem cells is essential for regenerative medicine and stem cell therapy, thereby propelling the demand over the forecast period.

The COVID-19 pandemic has positively impacted the market by accelerating diagnostics and therapeutic research advancements. The urgent need to understand the virus and develop effective treatments has stimulated investment in cutting-edge cell isolation technologies, facilitating the rapid isolation and analysis of rare immune cells and circulating viral particles. Thus, the growing demand has driven innovation and collaboration across the biotech industry, resulting in enhanced single-cell analysis, liquid biopsy, and personalized medicine capabilities, boosting the demand for rare cell isolation over the forecast period.

The increasing prevalence of chronic diseases, especially cancer, has significantly increased the demand for rare cell isolation techniques. Isolation of these cells allows for early diagnosis, monitoring of treatment efficacy, and development of targeted therapies tailored to individual patients. By capturing and studying these rare cells, researchers and clinicians are anticipated to identify specific genetic mutations, recognize tumor behavior, and devise personalized treatment plans, ultimately improving patient outcomes and advancing the field of oncology. Thus, the growing demand for rare cells in predicting behavior is estimated to propel the market growth over the forecast period.

However, advanced rare cell isolation technologies, such as microfluidics and flow cytometry, often require significant investment. The high equipment, reagents, and maintenance costs can be prohibitive for many research institutions and clinical labs, limiting market expansion. In addition, the processes involved in rare cell isolation are technically complex, thus requiring specialized expertise and training. This complexity is anticipated to create a barrier to adoption, further hampering the market's growth.

Rare Cell Isolation Market Report Highlights:

  • The reagent & kits segment dominated the market in 2023 and is expected to grow at the fastest CAGR from 2024 to 2030. The cost-effectiveness of reagents and kits compared to more sophisticated and expensive equipment for cell isolation plays a significant role in their widespread adoption
  • The stem cell type segment held the largest share of 39.46% in 2023. The pharmaceutical and biotechnology industries rely heavily on isolated stem cells to screen for new drugs, study cellular responses, and assess the safety of potential treatments. This widespread application in research and industry underpins the segment dominance
  • The microfluidics-based techniques technology segment dominated the market in 2023. Continuous innovation & advancements in microfluidics technology contributed to its leading position in the market. Researchers and companies are developing new microfluidic devices and methods that offer improved performance, ease of use, and integration with other analytical tools. These advancements are driving widespread adoption and expanding the applications of microfluidics-based cell isolation
  • North America dominated the market in 2023 due to the growing cancer incidence, sedentary lifestyle, and rising prevalence of chronic diseases. On the other hand, Asia Pacific is anticipated to grow at the highest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Products Segment
    • 1.2.2. Cell Type Segment
    • 1.2.3. Technology Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
    • 1.8.1. Total Market: CAGR Calculation
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Rare cell isolation market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic and rare diseases
      • 3.2.1.2. Technological advancement and innovation in cell isolation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Strict regulations and compliances for cell separation
  • 3.3. Rare Cell Isolation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Rare Cell Isolation Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Rare Cell Isolation Market Products Movement Analysis
  • 4.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Reagent & Kits
    • 4.4.1. Reagent & kits market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instrument
    • 4.5.1. Instrument market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Rare Cell Isolation Market: Cell Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Rare Cell Isolation Market Application Movement Analysis
  • 5.3. Global Rare Cell Isolation Market Size & Trend Analysis, by cell type, 2018 to 2030 (USD Million)
  • 5.4. Circulating Tumor Cells
    • 5.4.1. Circulating tumor cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Stem Cells
    • 5.5.1. Stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Fetal Cells
    • 5.6.1. Fetal cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Rare Immune Cells
    • 5.7.1. Rare immune cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Circulating Endothelial Cells
    • 5.8.1. Circulating endothelial cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Other Rare Cell Types
    • 5.9.1. Other rare cell types market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Rare cell isolation market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Rare Cell Isolation Market Technology Movement Analysis
  • 6.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 6.4. Microfluidics-based Techniques
    • 6.4.1. Microfluidics-based techniques market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Fluorescence-activated Cell Sorting
    • 6.5.1. Fluorescence-activated cell sorting market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Magnetic Bead Separation
    • 6.6.1. Magnetic bead separation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Rare cell isolation market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory framework
      • 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory framework
      • 7.5.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Miltenyi Biotec
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Thermo Fisher Scientific, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Danaher
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. QIAGEN N.V.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Bio-techne
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. STEMCELL Technologies
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. CELLENION
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. RareCyte
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Illumina, Inc.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Bio-Rad Laboratories, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • 1. List of abbreviation
  • 2. Global rare cell isolation market, by region, 2018 - 2030 (USD Million)
  • 3. Global rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 4. Global rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 5. Global rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 6. North America rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 7. North America rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 8. North America rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 9. North America rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 10. U.S. rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 11. U.S. rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 12. U.S. rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 13. Canada rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 14. Canada rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 15. Canada rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 16. Mexico rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 17. Mexico rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 18. Mexico rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 19. Europe rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 20. Europe rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 21. Europe rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 22. Europe rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 23. UK rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 24. UK rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 25. UK rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 26. Germany rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 27. Germany rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 28. Germany rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 29. France rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 30. France rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 31. France rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 32. Italy rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 33. Italy rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 34. Italy rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 35. Spain rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 36. Spain rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 37. Spain rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 38. Denmark rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 39. Denmark rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 40. Denmark rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 41. Sweden rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 42. Sweden rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 43. Sweden rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 44. Norway rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 45. Norway rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 46. Norway rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 47. Asia Pacific rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 48. Asia Pacific rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 49. Asia Pacific rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 50. Asia Pacific rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 51. Japan rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 52. Japan rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 53. Japan rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 54. China rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 55. China rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 56. China rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 57. India rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 58. India rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 59. India rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 60. Australia rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 61. Australia rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 62. Australia rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 63. South Korea rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 64. South Korea rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 65. South Korea rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 66. Thailand rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 67. Thailand rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 68. Thailand rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 69. Latin America rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 70. Latin America rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 71. Latin America rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 72. Latin America rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 73. Brazil rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 74. Brazil rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 75. Brazil rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 76. Argentina rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 77. Argentina rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 78. Argentina rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 79. MEA rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 80. MEA rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 81. MEA rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 82. MEA rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 83. South Africa rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 84. South Africa rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 85. South Africa rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 86. Saudi Arabia rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 87. Saudi Arabia rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 88. Saudi Arabia rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 89. UAE rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 90. UAE rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 91. UAE rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 92. Kuwait rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 93. Kuwait rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 94. Kuwait rare cell isolation market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • 1. Rare cell isolation market segmentation
  • 2. Data analysis models
  • 3. Market formulation and validation
  • 4. Data validating & publishing
  • 5. Market research process
  • 6. Information procurement
  • 7. Primary research
  • 8. Value-chain-based sizing & forecasting
  • 9. QFD modelling for market share assessment
  • 10. Market formulation & validation
  • 11. Commodity flow analysis
  • 12. Market outlook
  • 13. Segment snapshot-1
  • 14. Segment snapshot-2
  • 15. Competitive landscape snapshot
  • 16. Market trends & outlook
  • 17. Porter's five force analysis
  • 18. PESTEL analysis
  • 19. Rare cell isolation market: Products outlook key takeaways
  • 20. Rare cell isolation market: Products movement analysis
  • 21. Reagent & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • 22. Instrument market estimates and forecasts, 2018 - 2030 (USD Million)
  • 23. Rare cell isolation market: Cell type outlook key takeaways
  • 24. Rare cell isolation market: Cell type movement analysis
  • 25. Circulating tumor cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 26. Stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 27. Fetal cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 28. Rare immune cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 29. Circulating endothelial cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 30. Other rare cell types market estimates and forecasts, 2018 - 2030 (USD Million)
  • 31. Rare cell isolation market: Technology outlook key takeaways
  • 32. Rare cell isolation market: Technology movement analysis
  • 33. Magnetic bead separation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 34. Fluorescence-activated cell sorting market estimates and forecasts, 2018 - 2030 (USD Million)
  • 35. Microfluidics-based techniques market estimates and forecasts, 2018 - 2030 (USD Million)
  • 36. Regional marketplace outlook, 2023 & 2030 (USD Million)
  • 37. Regional marketplace: Key takeaways
  • 38. North America rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 39. Key country dynamics
  • 40. U.S. rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 41. Key country dynamics
  • 42. Canada rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 43. Key country dynamics
  • 44. Mexico rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 45. Europe rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 46. Key country dynamics
  • 47. UK rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 48. Key country dynamics
  • 49. Germany rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 50. Key country dynamics
  • 51. France rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 52. Key country dynamics
  • 53. Spain rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 54. Key country dynamics
  • 55. Italy rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 56. Key country dynamics
  • 57. Denmark rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 58. Key country dynamics
  • 59. Sweden rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 60. Key country dynamics
  • 61. Norway rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 62. Asia Pacific rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 63. Key country dynamics
  • 64. Japan rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 65. Key country dynamics
  • 66. China rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 67. Key country dynamics
  • 68. India rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 69. Key country dynamics
  • 70. Australia rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 71. Key country dynamics
  • 72. South Korea rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 73. Key country dynamics
  • 74. Thailand rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 75. Key country dynamics
  • 76. Market participant categorization
  • 77. Rare cell isolation market position analysis, 2023
  • 78. Strategic framework